Treating dyslipidemia in patients with type 2 diabetes mellitus without cardiovascular disease appears to result in a clinical benefit equivalent to or greater than that seen with treating non-diabetic cardiovascular disease patients.

Using a standard blood pressure (BP) cuff in obese subjects may result in overestimation of BP.

Treatment with rosiglitazone reduces hyperinsulinemia and improves artery elasticity in type 2 diabetic patients.

Insulin treatment achieves better results in patients with recent onset type 2 diabetes than does therapy with glibenclamide.

Pentoxifylline (PTF) reduces proteinuria and urinary excretion of N-acetyl-beta glucosaminidase (NAG) in patients with type 2 diabetes.

New defintion for metabolic syndrome consists of five easily measured variables linked to insulin reststance.

Years of treatment with statins may reduce the risk of psychological disorders, independently of the drugs’ impact on serum cholesterol levels.

Evidence mounts for low-glycemic index diet to control diabetes.

Experts believe they are a step closer to solving the riddle of the severe “neuropathic” pain.

The surgeon general recommends 10,000 steps per day, but 12,000-13,000 steps per day may be necessary for true weight loss.